Vident Advisory LLC Buys 904 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Vident Advisory LLC raised its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 11.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 8,972 shares of the medical equipment provider's stock after acquiring an additional 904 shares during the period. Vident Advisory LLC's holdings in Intuitive Surgical were worth $4,684,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of the business. Atala Financial Inc acquired a new stake in shares of Intuitive Surgical during the fourth quarter valued at about $25,000. Hurley Capital LLC acquired a new stake in Intuitive Surgical during the 4th quarter worth approximately $28,000. Berbice Capital Management LLC bought a new stake in Intuitive Surgical during the 4th quarter worth approximately $26,000. Parvin Asset Management LLC acquired a new position in Intuitive Surgical in the 4th quarter valued at approximately $26,000. Finally, BankPlus Trust Department bought a new position in shares of Intuitive Surgical during the fourth quarter valued at $28,000. Institutional investors and hedge funds own 83.64% of the company's stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on ISRG. Truist Financial cut their price target on shares of Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating on the stock in a report on Wednesday, April 23rd. Jefferies Financial Group upped their price target on Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. Citigroup reissued a "buy" rating and issued a $650.00 price target (up previously from $590.00) on shares of Intuitive Surgical in a research note on Thursday. Erste Group Bank lowered Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research note on Monday, March 17th. Finally, Barclays decreased their target price on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating for the company in a research report on Thursday, April 24th. Five equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $596.05.

Intuitive Surgical Trading Down 0.6%

ISRG stock traded down $3.13 during trading on Friday, reaching $539.54. 1,138,538 shares of the stock were exchanged, compared to its average volume of 1,644,578. The firm's 50 day moving average is $510.44 and its 200 day moving average is $537.67. The firm has a market cap of $193.38 billion, a P/E ratio of 84.17, a price-to-earnings-growth ratio of 5.85 and a beta of 1.70. Intuitive Surgical, Inc. has a twelve month low of $396.15 and a twelve month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.71 by $0.10. The company had revenue of $2.25 billion for the quarter, compared to analysts' expectations of $2.19 billion. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. During the same period last year, the business earned $1.50 EPS. As a group, analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, Director Jami K. Nachtsheim sold 2,400 shares of the business's stock in a transaction that occurred on Thursday, May 1st. The stock was sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the completion of the sale, the director now directly owns 6,371 shares of the company's stock, valued at approximately $3,312,920. The trade was a 27.36% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Myriam Curet sold 2,401 shares of Intuitive Surgical stock in a transaction that occurred on Thursday, February 27th. The shares were sold at an average price of $581.00, for a total value of $1,394,981.00. Following the transaction, the executive vice president now directly owns 353 shares in the company, valued at approximately $205,093. The trade was a 87.18% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 32,700 shares of company stock valued at $16,865,621 over the last three months. Corporate insiders own 0.70% of the company's stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.